Available to mentor
Jeremy Adler, M.D., M.Sc. is a Clinical Professor in the Division of Pediatric Gastroenterology at the University of Michigan and serves as research faculty in the Susan B. Meister Child Health Evaluation and Research (CHEAR) Center. Dr. Adler earned his M.D. degree at the University of South Florida College of Medicine. He completed his residency in pediatrics at Boston City Hospital and Boston Medical Center in 1997. He then practiced academic general pediatrics in New York for several years before moving to Michigan to train in pediatric gastroenterology at the University of Michigan. He then earned a Master of Science in Health and Health Care Research through in the Horace H. Rackham School of Graduate Studies at the University of Michigan, and had further training in the Advanced Improvement Methods program at Cincinnati Children’s Hospital. Dr. Adler joined the pediatric gastroenterology faculty at the University of Michigan in 2008.
Dr. Adler's clinical and research interest is in the care of children and adolescents with Crohn's disease and ulcerative colitis (inflammatory bowel disease or IBD). His research focus is on improving short and long-term outcomes and health related quality of life for children with IBD. He has been working on developing evidence-based strategies for preventing disease related complications such as fistulas and pouchitis, and to mitigate disparities among children with IBD.
Dr. Adler is an NIH-funded researcher whose scientific research has been featured in the American Gastroenterology Association's headline news, on the cover of the journal Inflammatory Bowel Diseases, and in the Innovations in Health Care section of the Wall Street Journal. Dr. Adler is a leader in the field of pediatric IBD, and has served as consultant to the US Food and Drug Administration, and his work on prevention of disease complications and on developing methods for evaluating endoscopic findings has been used in national and international policies and guidelines on treating children and adults with IBD. Dr. Adler also serves as the Director of Research and Quality Improvement in Pediatric Gastroenterology, and as the Director of the Pediatric IBD Program at C.S. Mott Children’s Hospital at Michigan Medicine.
-
Adaptive LeadershipUniversity of Michigan, United states, 2024
-
Linkage Leadership AcademyUniversity of Michigan, Ann Arbor, 2015
-
Advanced Improvement Methods (AIM), Center for Health Care QualityCincinnati Children's Hospital Medical Center, Cincinnati, 2013
-
Master of Science in Health and Health Care Research, Robert Wood Johnson Master's ProgramUniversity of Michigan Medical School, Ann Arbor, 2009
-
Pediatric gastroenterology FellowshipC. S. Mott Children's Hospital, Ann Arbor, 2008
-
Pediatric ResidencyBoston Medical Center, Boston, 1997
-
MScHorace H. Rackham School of Graduate Studies, University of Michigan, 2009
-
MDUniversity of South Florida College of Medicine, 1994
-
BSUniversity of Florida, 1990
-
Center MemberInstitute for Healthcare Policy and Innovation
Dr. Adler focuses on improving care of children and adolescents with Crohn's disease and ulcerative colitis. His research focus is on improving short and long-term outcomes and health related quality of life for children with IBD. He has been working on developing evidence-based strategies for preventing disease related complications such as fistulas and pouchitis, and to mitigate disparities among children with IBD.
-
Adler J, Gadepalli S, Rahman M, Kim S. Gut, 2025 Apr 1; 74 (4): 539 - 546.Journal ArticleEarly tumour necrosis factor antagonist treatment prevents perianal fistula development in children with Crohn's disease: Post hoc analysis of the RISK study
DOI:10.1136/gutjnl-2024-333280 PMID: 39667905 -
McLaughlin JF, Linville T, Jester TW, Marciano TA, Lazare F, Dotson JL, Samson C, Niklinska-Schirtz B, Cabrera J, Leibowtiz I, Batra S, Ammoury R, Strople JA, Saeed S, Sandberg KC, Tung J, Verstraete SG, Cox RF, Na S, Steiner SJ, Ali SA, Israel EJ, Dorsey J, Adler J, Rekhtman Y, Egberg MD, Waduge ER, Savas J, Brensinger CM, Lewis JD, Kappelman MD. Clinical Gastroenterology and Hepatology, 2025 Apr 1; 23 (5): 825 - 834.Journal ArticleTravel Time to Treating Center Is Associated With Diagnostic Delay in Pediatric Inflammatory Bowel Disease
DOI:10.1016/j.cgh.2024.07.027 PMID: 39181423 -
Constant BD, Adler J, Gold BD, Dotson J, Lightdale JR, Scott F, Saeed S, Kim S, Moses J, de Zoeten EF, Mirea L, Ritchey A, Pasternak B. JPGN Reports, 2025 Feb 12;Journal ArticleNational perspectives of barriers by insurance and pharmacy benefit managers in pediatric inflammatory bowel disease
DOI:10.1002/jpr3.70004 -
Patzer RE, Buford J, Urbanski M, McPherson L, Paul S, Di M, Harding JL, Katz-Greenberg G, Rossi A, Anand PM, Reeves-Daniel A, Jones H, Mulloy L, Pastan SO, Adams A, Adler J, Aiken S, Albanna H, Allison C, Andrews A, Atteritano J, Paul Ayuk-Arrey AT, Bailey J, Baker M, Baliga P, Barfield V, Begley B, Berlinger C, Berry S, Blythe E, Boulware E, Bowers M, Bowman K, Browne T, Burgess LA, Canavan K, Caponi S, Carlson A, Carter S, Chikhliker B, Chopra B, Cipriani K, Clynes D, Coe M, Collins B, Conroy MB, Daley D, Deitch J, Delong D, Detwiler R, Doshi M, Drew K, Drewry K, Dubay D, Dubbs J, Dunn D, Ellis M, Eneanya A, Fallahzadeh K, Farrell J, Flemming S, Florek E, Fogle C, France N, Fuller E, Gander J, Gani I, Gerido J, Gibney E, Gilbert F, Gilliard K, Givens JV, Goalby C, Godwin N, Goltz M, Gompers A, Good S, Grace T, Graves H, Gulotta J, Harrill J, Henry C, Hewitt A, Hippen B, Howard B, Wen A, Humphrey R, Hymes B, Imundo S, Jarvinian L, Johnson D, Johnson D, Jospeh J, Kahle E, Kauffman A, Kearns L, Kelty C, King C, Kiswii J. Clinical Journal of the American Society of Nephrology, 2025 Feb 1; 20 (2): 256 - 266.Journal ArticleReducing Disparities in Access to Kidney Transplantation Regional Study: A Randomized Trial in the Southeastern United States
DOI:10.2215/CJN.0000000586 PMID: 39671258 -
Dillman JR, Tkach JA, Fletcher JG, Bruining DH, Lu A, Kugathasan S, Alazraki AL, Knight-Scott J, Stidham RW, Adler J, Minar P, Trapnell BC, Bonkowski EL, Jurrell H, Lopez-Nunez O, Collins MH, Swanson SD, Fei L, Qian L, Towbin AJ, Kocaoglu M, Anton CG, Imbus RA, Dudley JA, Denson LA. Inflamm Bowel Dis, 2025 Jan 24;Journal ArticleCirculating and Magnetic Resonance Imaging Biomarkers of Intestinal Fibrosis in Small Bowel Crohn's Disease.
DOI:10.1093/ibd/izae319 PMID: 39853252 -
Adler J, Gadepalli S, group BS. Journal of Crohn's and Colitis, 2025 Jan 26; 19 (Supplement_1): i1507 - i1508.Journal ArticleP0781 Perianal lesions present at paediatric Crohn’s disease diagnosis require early treatment with tumour necrosis factor antagonist to reduce high risk of perianal fistulising complications: a post-hoc analysis of a prospective, multicentre study
DOI:10.1093/ecco-jcc/jjae190.0955 -
Gadepalli S, Adler J, group BS. Journal of Crohn's and Colitis, 2025 Jan 26; 19 (Supplement_1): i1948 - i1949.Journal ArticleP1057 Early use of tumour necrosis factor antagonist for treatment of paediatric Crohn’s disease decreases perianal fistula development: a post-hoc analysis of a prospective, multicentre study
DOI:10.1093/ecco-jcc/jjae190.1231 -
Dave S, Reed S, Shapiro M, Taye Y, Hernandez I, Kariyawasam N, Mehes I, Agrawal M, Regueiro M, Faye A, Adler J. Health Care Transitions, 2025 Jan 1; 3:Journal ArticleClinical trials and young adults with inflammatory bowel disease
DOI:10.1016/j.hctj.2025.100100
